相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Staging of Epithelial Maturation Using Secretory Cell-Specific Genes as Markers
Anna C. Zemke et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Validation of PON1 enzyme activity assays for longitudinal studies
Karen Huen et al.
CLINICA CHIMICA ACTA (2009)
Determinants of variation in human serum paraoxonase activity
D. L. Rainwater et al.
HEREDITY (2009)
Pesticide toxicity and the developing brain
Brenda Eskenazi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum POW activity in prepubertal children in Spain
Carmen Garces et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Dynamic variation in allele-specific gene expression of Paraoxonase-1 in murine and human tissues
Layla Parker-Katiraee et al.
HUMAN MOLECULAR GENETICS (2008)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma
Philip W. Connelly et al.
JOURNAL OF LIPID RESEARCH (2008)
Preparation and characterization of dialkylphosphoryl-obidoxime conjugates, potent anticholinesterase derivatives that are quickly hydrolyzed by human paraoxonase (PON1192Q)
J. Stenzel et al.
BIOCHEMICAL PHARMACOLOGY (2007)
An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat
Charles Timchalk et al.
TOXICOLOGICAL SCIENCES (2007)
Pesticides and their metabolites in the homes and urine of farmworker children living in the Salinas Valley, CA
Asa Bradman et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2007)
Prenatal pesticide and PCB exposures and birth outcomes
Mary S. Wolff et al.
PEDIATRIC RESEARCH (2007)
Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns
Nina Holland et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2006)
The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy:: findings from the British Women's Heart and Health cohort study
DA Lawlor et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2006)
Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece
GA Karikas et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
PM Erlich et al.
HUMAN MOLECULAR GENETICS (2006)
A long and winding road: defining the biological role and clinical importance of paraoxonases
Richard W. James
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Organophosphate urinary metabolite levels during pregnancy and after delivery in women living in an agricultural community
A Bradman et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2005)
Role of paraoxonase (PON1) status in pesticide sensitivity: Genetic and temporal determinants
CE Furlong et al.
NEUROTOXICOLOGY (2005)
Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism
TB Cole et al.
PHARMACOGENETICS AND GENOMICS (2005)
Genetic polymorphisms and activity of PON1 in a Mexican population
AE Rojas-García et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Paraoxonase-1 promoter polymorphism C-107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status
RW James et al.
PHARMACOGENETICS AND GENOMICS (2005)
Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates
JG Young et al.
NEUROTOXICOLOGY (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity
LG Costa et al.
CLINICA CHIMICA ACTA (2005)
In utero pesticide exposure, maternal paraoxonase activity, and head circumference
GS Berkowitz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres et al.
EXPERIMENTAL GERONTOLOGY (2004)
Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population
B Eskenazi et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Polymorphisms of the paraoxonase gene and risk of preterm delivery
DF Chen et al.
EPIDEMIOLOGY (2004)
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1
SP Deakin et al.
CLINICAL SCIENCE (2004)
Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis
E Zintzaras et al.
JOURNAL OF HUMAN GENETICS (2004)
Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population
N Ferré et al.
CLINICAL CHEMISTRY (2003)
Increased influence of genetic variation on PON1 activity in neonates
J Chen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position-107, implicating the Sp1 transcription factor
S Deakin et al.
BIOCHEMICAL JOURNAL (2003)
Expression of human paraoxonase (PON1) during development
TB Cole et al.
PHARMACOGENETICS (2003)
Paraoxonase gene polymorphisms, oxidative stress, and diseases
HL Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
PON1-192 phenotype and genotype assessments in 918 subjects of the Stanislas cohort study
M Vincent-Viry et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Pharmacogenomic considerations of the paraoxonase polymorphisms
CE Furlong et al.
PHARMACOGENOMICS (2002)
Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression
VH Brophy et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds
WF Li et al.
PHARMACOGENETICS (2000)
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype
GP Jarvik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
